Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
89Zr-NY008
- Development stage
- Phase 1
- Lead developer
- Norroy Bioscience
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics
- Administration
- Intravenous
01
Overview
89Zr-NY008 is a radiopharmaceutical and diagnostic agent developed by Norroy Bioscience. It consists of the monoclonal antibody NY008 labeled with the radioisotope zirconium-89 (89Zr), designed for use in positron emission tomography (PET) imaging. The primary mechanism involves targeting specific antigens associated with neoplastic and immune system diseases, enabling visualization of disease sites through PET scans. Its main clinical application under investigation is as an imaging agent for multiple myeloma, with additional exploration in solid tumors. The drug is currently in early phase 1 clinical trials to evaluate its safety and biodistribution in patients[1][2].
- Other names
- 89Zr-labeled NY008
Beyond the preview
Go deeper on 89Zr-NY008.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 89Zr-NY008.